The Oncosearch | Oncotarget

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Francesca De Felice, Giancarlo Dâ€™Ambrosio, Daniela Musio, Franco Iafrate, Ilaria Benevento, Marco Marzo, Marialaura Mancini, Federica Urbano, Marcella Iannitti, Francesco Marampon, Nadia Bulzonetti, Enrico Cortesi, Vincenzo Tombolini

Published Sep 14, 2018 · Vol. 9, No. 72 · pp. 33702-33709

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Barbara Vizio, Monica Boita, Carmen Cristiano, Jasenka Mazibrada, Ornella Bosco, Anna Novarino, Adriana Prati, Savino Sciascia, Giovanni Rolla, Libero Ciuffreda, Giuseppe Montrucchio, Graziella Bellone

Published Aug 28, 2018 · Vol. 9, No. 67 · pp. 32795-32809

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Gemma Bruera, Silvia Massacese, Stefania Candria, Antonio Galvano, Rosa Manetta, Aldo Victor Giordano, Sergio Carducci, Alessandra Di Sibio, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto, on behalf of Oncology Network ASL1 Abruz, Italy

Published Aug 7, 2018 · Vol. 9, No. 61 · pp. 31861-31876

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Gerolamo Bevivino, Silvia Sedda, Eleonora FranzÃ¨, Carmine Stolfi, Antonio Di Grazia, Vincenzo Dinallo, Flavio Caprioli, Federica Facciotti, Alfredo Colantoni, Angela Ortenzi, Piero Rossi, Giovanni Monteleone

Published Jul 27, 2018 · Vol. 9, No. 58 · pp. 31278-31290

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

MarÃa InÃ©s Molejon, Mirna Swayden, Daniele Fanale, Jennifer Bintz, Odile Gayet, Philippe Soubeyran, Juan Iovanna

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30837-30846

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Chiara Citterio, Michela Baccini, Elena Orlandi, Camilla Di Nunzio, Luigi Cavanna

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29801-29809

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells Research Paper

Anke Rauch, Annemarie Carlstedt, Claudia Emmerich, Al-Hassan M. Mustafa, Anja GÃ¶der, Shirley K. Knauer, Michael Linnebacher, Thorsten Heinzel, Oliver H. KrÃ¤mer

Published Jun 12, 2018 · Vol. 9, No. 45 · pp. 27835-27850

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway Correction

Mathieu Chocry, Ludovic Leloup, HervÃ© Kovacic

Published Jun 1, 2018 · Vol. 9, No. 42 · pp. 26978-26979

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2 Research Paper

Ya-Min Cheng, Po-Lin Lin, De-Wei Wu, Lee Wang, Chi-Chou Huang, Huei Lee

Published May 29, 2018 · Vol. 9, No. 41 · pp. 26342-26352

Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin Research Paper

Weiqi Huang, Ling Bei, Elizabeth A. Eklund

Published May 25, 2018 · Vol. 9, No. 40 · pp. 25891-25902

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Jacopo Junio Valerio Branca, Mario Maresca, Gabriele Morucci, Matteo Becatti, Ferdinando Paternostro, Massimo Gulisano, Carla Ghelardini, Daniela Salvemini, Lorenzo Di Cesare Mannelli, Alessandra Pacini

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23426-23438

Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production Research Paper

Azin Jafari, Hanno Matthaei, Sven Wehner, Tolga Tonguc, JÃ¶rg C. Kalff, Steffen Manekeller

Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 21797-21810

Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer Research Paper

Gemma Bruera, Silvia Massacese, Antonio Galvano, Antonella Dal Mas, Stefano Guadagni, Giuseppe Calvisi, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto, on behalf of Oncology Network ASL1 Abruzzo, Italy

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20339-20350

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer Research Paper

Tomohiro Kondo, Masashi Kanai, Tadayuki Kou, Tomohiro Sakuma, Hiroaki Mochizuki, Mayumi Kamada, Masahiko Nakatsui, Norimitsu Uza, Yuzo Kodama, Toshihiko Masui, Kyoichi Takaori, Shigemi Matsumoto, Hidehiko Miyake, Yasushi Okuno, Manabu Muto

Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19817-19825

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer Research Paper

Akira Okita, Shin Takahashi, Kota Ouchi, Masahiro Inoue, Mika Watanabe, Mareyuki Endo, Hiroshi Honda, Yasuhide Yamada, Chikashi Ishioka

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18698-18711

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, Masato Nakamura, Hiroshi Nakayama, Manabu Shiozawa, Akitaka Makiyama, Kazuma Kobayashi, Yutaro Kubota, Misuzu Mori, Masahito Kotaka, Akinori Takagane, Masahiro Gotoh, Masahiro Takeuchi, Masashi Fujii, Wararu Ichikawa, Takashi Sekikawa

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 18811-18820

Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer Clinical Research Papers

Gemma Bruera, Mario Di Staso, Pierluigi Bonfili, Antonio Galvano, Rosa Manetta, Gino Coletti, Roberto Vicentini, Stefano Guadagni, Corrado Ficorella, Ernesto Di Cesare, Antonio Russo, Enrico Ricevuto

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17906-17914

Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids Research Paper

Mans Broekgaarden, Imran Rizvi, Anne-Laure Bulin, Ljubica Petrovic, Ruth Goldschmidt, Jonathan P. Celli, Tayyaba Hasan

Published Feb 6, 2018 · Vol. 9, No. 16 · pp. 13009-13022

MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1 Research Paper

Hui Liu, Xin-Hua Cheng

Published Feb 1, 2018 · Vol. 9, No. 15 · pp. 12304-12315

Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer Research Paper

Yujiro Nishizawa, Masamitsu Konno, Ayumu Asai, Jun Koseki, Koichi Kawamoto, Norikatsu Miyoshi, Hidekazu Takahashi, Naohiro Nishida, Naotsugu Haraguchi, Daisuke Sakai, Toshihiro Kudo, Taishi Hata, Chu Matsuda, Tsunekazu Mizushima, Taroh Satoh, Yuichiro Doki, Masaki Mori, Hideshi Ishii

Published Dec 21, 2017 · Vol. 9, No. 7 · pp. 7476-7486

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells Research Paper

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway Correction

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2 Research Paper

Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin Research Paper

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production Research Paper

Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer Research Paper

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer Research Paper

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer Research Paper

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer Clinical Research Papers

Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids Research Paper

MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1 Research Paper

Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study Research Paper

Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: expression and prognostic significance Research Paper

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study Research Paper

Follistatin-like protein 1 sustains colon cancer cell growth and survival Research Paper

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma Research Paper

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis Meta-Analysis

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells Research Paper

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway Correction

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2 Research Paper

Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin Research Paper

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production Research Paper

Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer Research Paper

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer Research Paper

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer Research Paper

A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 Research Paper

Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer Clinical Research Papers

Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids Research Paper

MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1 Research Paper

Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer Research Paper